Unit
- Manufacturing lifecycle: Pharmaceutical production follows a defined lifecycle from raw material receipt through processing, packaging, and distribution. Each stage has critical process parameters that must be monitored and controlled.
- Regulatory framework: Operations must comply with current Good Manufacturing Practices (cGMP) enforced by agencies such as the FDA and EMA. These regulations ensure product safety, efficacy, and quality.
- Process types: Common unit operations include blending, granulation, compression, coating, and filling. The choice of process depends on dosage form (tablet, capsule, injectable) and product characteristics.
- Quality by Design (QbD): A systematic approach to development that begins with predefined objectives and emphasizes product and process understanding based on sound science and risk management.
- Facility classifications: Manufacturing areas are classified by cleanliness standards (ISO 5 to ISO 8) to control particulate and microbial contamination. Aseptic operations require stricter controls.
- Equipment qualification: All equipment must undergo installation qualification (IQ), operational qualification (OQ), and performance qualification (PQ) before routine use.
- Personnel practices: Operators must follow gowning procedures, hygiene protocols, and training requirements to prevent contamination. Gowning is critical in classified areas.
- Documentation system: Batch records, standard operating procedures (SOPs), and logbooks form the backbone of compliance. Every action must be documented per the documentation hierarchy.
- Cleaning validation: Ensures equipment is free of residues between batches. Validated cleaning procedures must demonstrate removal of active ingredients, cleaning agents, and microbial contaminants. Limits are based on toxicological data and visual inspection. Swab and rinse samples are analyzed using validated analytical methods.
- Process validation: A documented program that provides high assurance that a process consistently produces product meeting specifications. It includes process design, qualification, and continued verification. Traditional three batches approach or continuous process verification using PAT.
- Deviation management: Any unplanned event that deviates from approved procedures must be documented, investigated, and resolved. Root cause analysis identifies corrective and preventive actions (CAPA). Timely closure and effectiveness checks are required to prevent recurrence.
- Supply chain management: Raw materials and components must be sourced from qualified suppliers. Audits, material specifications, and incoming testing ensure quality. Cold chain logistics for temperature-sensitive products require monitoring and validation of shipping containers.
- Technology transfer: Moving a product from development to commercial manufacturing involves transferring knowledge, methods, and processes. A transfer plan, gap analysis, and scale-up studies are conducted. Success criteria include process performance and comparability of product quality.
Code Example
Batch Record Snippet
Batch Record: 2024-09-001
Product: Placebo Tablet 500 mg
Step: Weighing
Material: Microcrystalline Cellulose
Target Quantity: 50.0 kg
Actual Quantity: 50.1 kg
Operator: J. Smith
Verifier: M. Johnson
Timestamp: 2024-09-15 08:30
Comment: within +/-2% toleranceThis is a simplified batch record entry showing critical process step with operator and verifier signatures. Each entry requires immediate documentation to maintain data integrity.
Quick Revision
- Pharmaceutical manufacturing follows a controlled lifecycle under cGMP regulations.
- Quality by Design (QbD) emphasizes systematic development and risk management.
- Facilities have classified cleanliness zones; equipment must be qualified before use.
- Documentation is essential for compliance; all actions must be recorded.